Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Serra

Showing results (21-30 of 154) with videos related to

Pageof 16
Sort By:
Expert Opinion on Emerging Drugs|August 13, 2019
An update on emerging drugs in osteosarcoma: towards tailored therapies?Claudia Maria Hattinger, Maria Pia Patrizio, Federica Magagnoli, et al.
Polymers|May 25, 2024
Polyglycerol Sebacate Elastomer: A Critical Overview of Synthetic Methods and Characterisation TechniquesMariella Rosalia, Davide Rubes, Massimo Serra, et al.
Pharmacogenomics|November 25, 2016
Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patientsClaudia M Hattinger, Serena Vella, Elisa Tavanti, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 21, 2016
Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcomaClaudia Maria Hattinger, Elisa Tavanti, Marilù Fanelli, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 2, 2019
Current understanding of pharmacogenetic implications of DNA damaging drugs used in osteosarcoma treatmentClaudia Maria Hattinger, Maria Pia Patrizio, Silvia Luppi, et al.
Scientific Reports|December 5, 2024
Selective delivery of G-quadruplex ligand in glioma cell lines: the power of cyclic-RGD peptideValentina Pirota, Giovanni Bisbano, Amanda Oldani, et al.
Cancers|July 2, 2021
Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment StrategiesClaudia Maria Hattinger, Maria Pia Patrizio, Leonardo Fantoni, et al.
Molecules (Basel, Switzerland)|May 14, 2022
Controlled Decoration of [60]Fullerene with Polymannan Analogues and Amino Acid Derivatives through Malondiamide-Based LinkersLisa Tanzi, Davide Rubes, Teodora Bavaro, et al.
Future Oncology (London, England)|February 11, 2017
Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?Claudia M Hattinger, Marilù Fanelli, Elisa Tavanti, et al.
International Journal of Oncology|October 4, 2018
An RGD small-molecule integrin antagonist induces detachment-mediated anoikis in glioma cancer stem cellsMayra Paolillo, Marisa C Galiazzo, Antonio Daga, et al.
Pageof 16

Showing results (21-30 of 154) with videos related to

Sort By:
Pageof 16
Expert Opinion on Emerging Drugs|August 13, 2019
An update on emerging drugs in osteosarcoma: towards tailored therapies?Claudia Maria Hattinger, Maria Pia Patrizio, Federica Magagnoli, et al.
Polymers|May 25, 2024
Polyglycerol Sebacate Elastomer: A Critical Overview of Synthetic Methods and Characterisation TechniquesMariella Rosalia, Davide Rubes, Massimo Serra, et al.
Pharmacogenomics|November 25, 2016
Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patientsClaudia M Hattinger, Serena Vella, Elisa Tavanti, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 21, 2016
Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcomaClaudia Maria Hattinger, Elisa Tavanti, Marilù Fanelli, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 2, 2019
Current understanding of pharmacogenetic implications of DNA damaging drugs used in osteosarcoma treatmentClaudia Maria Hattinger, Maria Pia Patrizio, Silvia Luppi, et al.
Scientific Reports|December 5, 2024
Selective delivery of G-quadruplex ligand in glioma cell lines: the power of cyclic-RGD peptideValentina Pirota, Giovanni Bisbano, Amanda Oldani, et al.
Cancers|July 2, 2021
Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment StrategiesClaudia Maria Hattinger, Maria Pia Patrizio, Leonardo Fantoni, et al.
Molecules (Basel, Switzerland)|May 14, 2022
Controlled Decoration of [60]Fullerene with Polymannan Analogues and Amino Acid Derivatives through Malondiamide-Based LinkersLisa Tanzi, Davide Rubes, Teodora Bavaro, et al.
Future Oncology (London, England)|February 11, 2017
Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?Claudia M Hattinger, Marilù Fanelli, Elisa Tavanti, et al.
International Journal of Oncology|October 4, 2018
An RGD small-molecule integrin antagonist induces detachment-mediated anoikis in glioma cancer stem cellsMayra Paolillo, Marisa C Galiazzo, Antonio Daga, et al.
Pageof 16